Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Market Closed - Nasdaq Other stock markets 04:00:01 2024-05-31 pm EDT			5-day change	1st Jan Change
142.6 ^USD	-5.89%		-14.43%	+43.36%

May. 31	Health Care Stocks Climb On Drug News -- Health Care Roundup	DJ
May. 31	Equities Mostly Rise as Fed's Preferred Inflation Measure Meets Street Views	MT

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ad9b1.ZCgP5SJjq78Qxu0brF3q6oOBqOEw4CW9tYiiqTIFtzY.DGA-gGVbmclci6N91iybrvnz6oJb0W7y_MDDxFFu-EIQRn2nbCXvy0f2hg~633740effe27d01907b80a7d19088ef4

Analyst Recommendations on Moderna, Inc.

RBC Raises Moderna's Price Target to $160 From $135	May. 31	MT
Moderna Insider Sold Shares Worth $1,909,863, According to a Recent SEC Filing	May. 20	MT
Moderna Insider Sold Shares Worth $1,912,350, According to a Recent SEC Filing	May. 17	MT
Arbutus Biopharma Urged to Stop Share Issuances, Explore Alternatives for Hepatitis B Program	May. 17	MT
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor...	May. 14
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target	May. 14	MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing	May. 13	MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70	May. 09	MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating	May. 07	MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET	May. 06	DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing	May. 06	MT
Jefferies Adjusts Price Target on Moderna to $155 From $125	May. 03	MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142	May. 03	MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206	May. 03	MT
Leerink Adjusts Price Target on Moderna to $60 From $59	May. 03	MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89	May. 03	MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125	May. 03	MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206	May. 03	MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating	May. 03	MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating	May. 03	MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna...	May. 03
MODERNA : price target raised by Oddo BHF	May. 03	CF
RBC Raises Price Target on Moderna to $135 From $125	May. 02	MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating	May. 02	MT
Moderna Secures Contract to Supply 12.5 Million COVID-19 Vaccine Doses to Brazil	Apr. 22	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

142.6 USD

Average target price

139.9 USD

Spread / Average Target

-1.83%

High Price Target

310 USD

Spread / Highest target

+117.47%

Low Price Target

62 USD

Spread / Lowest Target

-56.51%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

RBC Capital Markets
Evercore ISI
Deutsche Bank Securities
UBS
Jefferies & Co.
Oppenheimer
Goldman Sachs
Leerink Partners
Morgan Stanley
Redburn
HSBC
Canaccord Genuity
RBC	Luca Issi
JPMorgan Chase
Argus
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase

Ratings for Moderna, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar